Results 81 to 90 of about 24,129,507 (192)

Genetic polymorphism and natural selection of Duffy binding protein of Plasmodium vivax Myanmar isolates

open access: yesMalaria Journal, 2012
Background Plasmodium vivax Duffy binding protein (PvDBP) plays an essential role in erythrocyte invasion and a potential asexual blood stage vaccine candidate antigen against P. vivax.
Ju Hye-Lim   +9 more
doaj   +1 more source

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea [PDF]

open access: yes, 2015
Drug resistance remains a major obstacle to malaria treatment and control. It can arise and spread rapidly, and vary substantially even at sub-national level.
Jonah Iga (175169)   +32 more
core   +1 more source

Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 [PDF]

open access: yes, 2014
Background: Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan.
Abdisalan M. Noor (82579)   +45 more
core   +1 more source

Development of PCR–RFLP assay for the discrimination of Plasmodium species and variants of P. vivax (VK210, VK247 and P. vivax-like) in Anopheles mosquitoes

open access: yesActa Tropica, 2011
The identification of Plasmodium species in Anopheles mosquitoes is an integral component of malaria control programs. We developed a new assay to identify Plasmodium falciparum, Plasmodium malariae, and Plasmodium vivax variants. Specific primers were designed to hybridize to CS gene-specific regions.
Cassiano, Gustavo Capatti   +5 more
openaire   +2 more sources

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies [PDF]

open access: yes, 2013
Background: This study aimed to synthesize available evidence on the efficacy of dihydroartemisinin-piperaquine (DHP) in treating uncomplicated Plasmodium vivax malaria in people living in endemic countries.
Cho Naing (492196)   +27 more
core   +1 more source

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax : a randomized controlled trial [PDF]

open access: yes, 2012
BACKGROUND: Intermittent preventive treatment in infants (IPTi) has been shown in randomized trials to reduce malaria-related morbidity in African infants living in areas of high Plasmodium falciparum (Pf) transmission. It remains unclear whether IPTi is
Reeder, J. C.   +102 more
core   +1 more source

Transmission of Plasmodium vivax in South-Western Uganda: Report of Three Cases in Pregnant Women [PDF]

open access: yes, 2011
Plasmodium vivax is considered to be rare in the predominantly Duffy negative populations of Sub-Saharan Africa, as this red blood cell surface antigen is essential for invasion by the parasite.
Nyehangane, D   +25 more
core   +1 more source

Acquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC).

open access: yesPLoS ONE, 2010
BackgroundPolymorphism of the Duffy Antigen Receptor for Chemokines (DARC) is associated with susceptibility to and the severity of Plasmodium vivax malaria in humans. P. vivax uses DARC to invade erythrocytes. Individuals lacking DARC are 'resistant' to
Amanda Maestre   +12 more
doaj   +1 more source

Profiling vivax malaria incidence, residual transmission, and risk factors using reactive case detection in low transmission settings of Ethiopia

open access: yesMalaria Journal
Background Identification of local Plasmodium vivax transmission foci and its hidden reservoirs are crucial to eliminating residual vivax malaria transmission. This study assessed whether reactive case detection (RCD) could better identify P. vivax cases
Ashenafi Abossie   +13 more
doaj   +1 more source

Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.

open access: yesPLoS Medicine, 2007
BackgroundPlasmodium vivax invasion requires interaction between the human Duffy antigen on the surface of erythrocytes and the P. vivax Duffy binding protein (PvDBP) expressed by the parasite. Given that Duffy-negative individuals are resistant and that
Brian T Grimberg   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy